Lori M. van Roozendaal
Papers
1
Total Citations
10
H-Index
1
About
Dr. Lori M. van Roozendaal is a pioneering thoracic surgeon whose research is reshaping the landscape of minimally invasive lung cancer surgery. Her primary focus lies in optimizing surgical precision and patient outcomes, with a key contribution being the advancement of near-infrared fluorescence imaging using indocyanine green (ICG). Her landmark 2024 systematic review, which has already garnered 10 citations, rigorously evaluated the efficacy of intravenous ICG in identifying intersegmental planes during video- and robot-assisted thoracoscopic segmentectomies. This work provides critical, evidence-based guidance for surgeons, helping to reduce the risk of incomplete resections and preserve healthy lung tissue. Beyond this, Dr. van Roozendaal is actively investigating strategies to minimize postoperative complications, such as air leaks, and to enhance the safety of complex procedures. Her research is not only technically innovative but also deeply patient-centered, aiming to make lung cancer surgery safer and more effective. With a growing citation record reflecting the immediate relevance of her work, Dr. van Roozendaal is establishing herself as a leading voice in the evolution of thoracic surgery toward more precise, less invasive techniques.
Research Focus
Key Achievements
Top Papers
- 1